Oaktree Acquisition Corp. III Life Sciences (OACC) total debt
Only 2 fiscal years of total debt are on record here for Oaktree Acquisition Corp. III Life Sciences (OACC); a history needs at least 3. Figures as of 18 Nov 2026, 09:48 UTC, from Yahoo Finance.
Key facts
- Total debt, fiscal 2025
- $11.82K
- Change on fiscal 2024
- 0.0%
- Fiscal years on record
- 22024–2025
Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.
Not enough data
A history of total debt needs at least 3 fiscal years; 2 are on record here for Oaktree Acquisition Corp. III Life Sciences. Nothing is estimated to fill the gap. What is on record is in the table below.
Oaktree Acquisition Corp. III Life Sciences total debt, year by year
| Fiscal year | Total debt | Change | Year ended | Debt ÷ equity |
|---|---|---|---|---|
| 2025 | $11.82K | 0.0% | 0.0× | |
| 2024 | $11.82K | — | 0.0× |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.
How to read it
Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.
Oaktree Acquisition Corp. III Life Sciences, figure by figure
- Oaktree Acquisition Corp. III Life Sciences market cap
- Oaktree Acquisition Corp. III Life Sciences revenue
- Oaktree Acquisition Corp. III Life Sciences earnings
- Oaktree Acquisition Corp. III Life Sciences earnings per share (EPS)
- Oaktree Acquisition Corp. III Life Sciences P/E ratio
- Oaktree Acquisition Corp. III Life Sciences P/S ratio
- Oaktree Acquisition Corp. III Life Sciences P/B ratio
- Oaktree Acquisition Corp. III Life Sciences free cash flow
- Oaktree Acquisition Corp. III Life Sciences operating margin
- Oaktree Acquisition Corp. III Life Sciences dividend
- Oaktree Acquisition Corp. III Life Sciences shares outstanding
- Oaktree Acquisition Corp. III Life Sciences cash on hand
- Oaktree Acquisition Corp. III Life Sciences total assets
- Oaktree Acquisition Corp. III Life Sciences return on equity (ROE)
- Oaktree Acquisition Corp. III Life Sciences return on invested capital (ROIC)
Oaktree Acquisition Corp. III Life Sciences (OACC) overview: price, valuation and scorecard
Oaktree Acquisition Corp. III Life Sciences total debt: questions and answers
How is Oaktree Acquisition Corp. III Life Sciences's total debt calculated?
Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Oaktree Acquisition Corp. III Life Sciences it is on record here for 2 fiscal years, 2024 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: total debt
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Oaktree Acquisition Corp. III Life Sciences (OACC) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/OACC/total-debt
Underlying data: Yahoo Finance.